HARVARD BIOSCIENCE, INC. Shareholders' Equity
HARVARD BIOSCIENCE, INC. (HBIO) had Shareholders' Equity of $7.42 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $7.42M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $10.05M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $13.73M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $14.07M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $7.42M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $10.05M 10-Q · filed 2026-08-11 |
| 2025-12-31 | $13.73M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $14.07M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $15.73M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $14.84M 10-Q · filed 2026-08-11 |
| 2024-12-31 | $63.34M 10-Q · filed 2026-08-11 |
| 2024-09-30 | $65.32M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $67.25M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $68.81M 10-Q · filed 2025-08-11 |
| 2023-12-31 | $73.07M 10-K · filed 2026-03-13 |
| 2023-09-30 | $74.29M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $75.39M 10-Q · filed 2024-11-08 |
| 2023-03-31 | $74.34M 10-Q · filed 2024-08-08 |
| 2022-12-31 | $72.22M 10-K · filed 2025-03-14 |
| 2022-09-30 | $71.98M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $77.50M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $76.38M 10-Q · filed 2023-08-08 |
| 2021-12-31 | $83.40M 10-K · filed 2024-03-07 |
| 2021-09-30 | $76.89M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $78.70M 10-Q · filed 2022-11-09 |
| 2021-03-31 | $77.11M 10-Q · filed 2022-08-04 |
| 2020-12-31 | $76.68M 10-K · filed 2023-03-09 |
| 2020-09-30 | $77.17M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $76.07M 10-Q · filed 2021-11-05 |
| 2020-03-31 | $76.01M 10-Q · filed 2021-08-06 |
| 2019-12-31 | $81.69M 10-K · filed 2022-03-11 |
| 2019-09-30 | $77.10M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $80.33M 10-Q · filed 2020-11-06 |
| 2019-03-31 | $80.35M 10-Q · filed 2020-08-10 |
| 2018-12-31 | $82.72M 10-K/A · filed 2021-03-17 |
| 2018-09-30 | $80.96M 10-Q · filed 2019-11-08 |
| 2018-06-30 | $77.01M 10-Q · filed 2019-11-08 |
| 2018-03-31 | $79.29M 10-Q · filed 2019-08-08 |
| 2017-12-31 | $80.90M 10-K · filed 2020-03-16 |
| 2017-09-30 | $76.91M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $75.21M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $72.72M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $72.20M 10-K · filed 2019-03-18 |
| 2016-09-30 | $75.89M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $76.66M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $78.19M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $77.60M 10-K · filed 2018-03-16 |
| 2015-09-30 | $94.29M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $94.81M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $90.50M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $95.47M 10-K · filed 2018-03-16 |
| 2014-09-30 | $96.78M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $98.23M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $96.18M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $94.48M 10-K · filed 2017-03-17 |
| 2013-09-30 | $107.83M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $105.38M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $104.38M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $104.21M 10-K · filed 2016-04-29 |
| 2012-09-30 | $100.36M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $98.02M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $98.11M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $95.50M 10-K · filed 2015-03-12 |
| 2011-09-30 | $95.98M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $96.81M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $90.25M 10-K · filed 2014-03-14 |
| 2009-12-31 | $75.26M 10-K · filed 2013-03-18 |
| 2008-12-31 | $66.72M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |